21 CFR Part 11 Regulatory Intelligence (FDA/EMA) — Real‑Time Alerts & eQMS Mapping

Turn regulatory change into validated work. Parakeet normalizes FDA/EMA signals, maps them to SOPs/CAPA/change control in your eQMS, and preserves Part 11–aligned records, signatures, and audit trails.

• See pharma fit and data integrity on our Pharma page

• Explore always‑on monitoring on Continuous Compliance

TPRM for Life Sciences: eQMS Integration + 21 CFR Part 11 Supplier Monitoring — Real‑Time FDA/EMA Alerts (2026)

Parakeet unifies eQMS workflows and Third‑Party Risk Management for pharma. Real‑time FDA/EMA signals route to owners, open tasks in your QMS, and extend to supplier oversight—backed by role‑based e‑signatures, human‑readable copies, and configurable 21 CFR Part 11 audit trails.

eQMS task creation (examples)

• Gap analysis tasks mapped to SOPs/controls with owners and due dates

• Change control creation with SLAs, approvers, and full audit trails

• CAPA initiation with verification/validation steps and traceability

• Policy/control update tasks linked to impacted procedures and records

• Vendor assessments, SCARs, and requalification tied to supplier records

Get started

• See pharma fit and data integrity under Part 11 on our Pharma page

• Request a Validation Pack to document intended use and kickstart validation

FAQ — eQMS Task Creation & Validation

• Which eQMS tasks can Parakeet auto‑create? Gap analysis, change control, CAPA, and policy/control update tasks, plus supplier workflows (assessments, SCARs, requalification) mapped to your QMS and vendor records.

• How do alerts become QMS work? We normalize FDA/EMA notices and apply routing rules to auto‑create tasks in your eQMS and TPRM workflows with owners, SLAs, and audit trails.

• How is 21 CFR Part 11 addressed? Electronic records/signatures, audit trails, retention, and human‑readable copies are maintained in line with Part 11 scope and enforcement guidance. Validate intended use with our Validation Pack.

• Do you align with ICH Q9 and ISO 14971? Yes. Signals map to QRM artifacts (risk registers, matrices, FMEA/FMECA, hazard analyses) with traceability to controls, CAPAs, and change control in your eQMS.> 21 CFR Part 11 continuous monitoring

  Tie FDA/EMA regulatory signals to eQMS tasks with full audit trails, role‑based e‑signatures, and human‑readable copies.

  • Learn how we support Part 11 on our Pharma page
  • Request a Validation Pack to document intended use and kickstart validation

Answer at a glance Parakeet unifies eQMS and Third‑Party Risk for pharma: real‑time FDA/EMA alerts route to owners, open QMS tasks, and maintain 21 CFR Part 11 audit trails. Validate intended use, stay audit‑ready, and keep CMOs/CROs continuously compliant.

• Real‑time regulatory signal layer (FDA/EMA) mapped to SOPs, CAPA, and change control in your eQMS
• 21 CFR Part 11–aligned records, signatures, and configurable audit trails
• Supplier oversight: certifications, SCARs, and vendor requalification triggered automatically

Sample alert card • Source: FDA — Drug Shortages (DSS) • Signal: New shortage — Heparin (multi‑dose); status: current; reason: increased demand • Auto‑actions: Create supply allocation plan; open vendor assessment; start change control • QMS mapping: SOP‑SUP‑012, CC‑004; Owner: Supply Chain; SLA: 3 business days> Coverage & cadence (authoritative sources) - FDA — Guidance Documents (incl. CDER): real-time + weekly digest - FDA — Recalls/Market Withdrawals/Safety Alerts: real-time - FDA — Drug Shortages (DSS): real-time + daily batch - EMA — Scientific Guidelines (human medicines): real-time + weekly digest - EMA — Direct Healthcare Professional Communications (DHPC): real-time - EMA — ESMP/Shortages catalogues: real-time + daily batch - EMA — CTIS newsflashes/newsletters: weekly

What routes to your eQMS (at a glance) - SOP/policy gap analysis tasks mapped to controls with owners and due dates - Change control and CAPA creation with role-based e‑signatures and audit trails - Vendor assessments/SCARs/requalification tied to supplier records and SLAs

Delivery examples (Slack/Teams) - Slack (#reg‑intel): “FDA Guidance Issued — Data Integrity in Analytical Methods → Gap analysis due Nov 12, 2025” Slack integration - Teams (Regulatory Affairs): “EMA DHPC — Aflibercept: Update RMP; start change control” Microsoft Teams integration

TPRM for Life Sciences: eQMS Integration + 21 CFR Part 11 Supplier Monitoring> What’s new — Updated November 25, 2025

Added explicit Part 11 validation guidance and links for pharma teams.

Part 11 & eQMS (read this first)

• FDA doesn’t certify Part 11; validate your use.

What this means: your Quality team is responsible for validating intended use of Parakeet within your QMS (records, signatures, audit trails, retention, and copies). Parakeet supports CSA/CSV activities with configurable audit trails, role‑based e‑signatures, and exportable, human‑readable records mapped to your SOPs and CAPA/change‑control workflows.

Resources

• Part 11 approach and pharma fit: see our Pharma page for data integrity and audit trails under 21 CFR Part 11.

• Request a Validation Pack to document intended use and kickstart validation.

Signal layer for eQMS/TPRM

Parakeet’s regulatory signal layer normalizes FDA and EMA notices and routes them to owners, opening tasks in your eQMS and TPRM workflows with full 21 CFR Part 11 audit trails.

Covered feeds (at a glance)

• FDA: Guidance Documents (incl. CDER), Recalls/Market Withdrawals/Safety Alerts, Drug Shortages (DSS)

• EMA: Scientific Guidelines, DHPCs, ESMP/Shortages catalogues, CTIS/newsflashes

Key routing fields | Field | What it means | Example | |---|---|---| | issue_date | Publication date of the notice | 2025-10-02 | | effective_date | When requirements take effect (if stated) | 2025-10-02 | | compliance_deadline | Due date for required actions (derived or stated) | 2025-11-12 |

Note: Electronic records, e‑signatures, and audit trails for these alerts are maintained in line with 21 CFR Part 11 scope and enforcement guidance, with human‑readable copies for auditors. Parakeet unifies eQMS workflows with Third‑Party Risk Management to keep CMOs, CROs, and GxP vendors continuously compliant. Get real‑time FDA/EMA alerts that open tasks in your QMS, orchestrate vendor audits, automate supplier certification tracking, and generate audit‑ready evidence with full Part 11 audit trails.

TPRM for Life Sciences (eQMS + 21 CFR Part 11): Real‑Time Regulatory Alerts

Life‑sciences teams use Parakeet to bridge eQMS and Third‑Party Risk Management (TPRM). Your eQMS governs internal quality records, CAPAs, and change control; TPRM ensures CMOs, CROs, API suppliers, and GxP vendors stay compliant. Parakeet unifies both with real‑time FDA/EMA alerts that automatically route to owners, open tasks in your QMS, and extend to vendor qualification, contract/manufacturing changes, and supplier corrective actions—backed by 21 CFR Part 11 supplier monitoring and complete audit trails.

• Monitor suppliers against FDA/EMA changes in real time; trigger vendor assessments, SCARs, and change controls mapped to your QMS.

• Maintain continuous oversight of third‑party certifications, data integrity expectations, and labeling/safety obligations linked to your products.

• Deliver alerts where work happens (Slack/Teams) and keep traceability across internal and supplier workflows via Parakeet + eQMS integrations.

This page details the regulatory signal layer that powers both eQMS workflows and TPRM supplier oversight. Explore our broader pharma fit on Pharma and always‑on monitoring on Continuous Compliance.

Introduction

Pharmaceutical teams use Parakeet Risk to centralize regulatory intelligence from FDA and EMA, translate changes into actionable tasks, and deliver real‑time alerts in Slack and Microsoft Teams. Built for GMP-regulated environments, Parakeet enriches each signal with context, routes it to the right owner, and preserves a complete audit trail mapped to your QMS and CAPA workflows. See industry fit on our Pharma solution page and always‑on monitoring on Continuous Compliance.

What we monitor (FDA/EMA) and how it’s used

• FDA guidance issuances and updates, via the centralized Guidance Document search and CDER-specific filters, used to trigger policy/control reviews and gap analyses.

• FDA recalls, market withdrawals, and safety alerts to initiate change control, labeling checks, and field action readiness.

• FDA drug shortages (current/resolved), including DSS updates, to inform supply planning, allocation decisions, and alternative sourcing.

• EMA scientific guidelines (quality/nonclinical/clinical/biologicals) to align dossiers and validation plans with the latest EU expectations.

• EMA Direct Healthcare Professional Communications (DHPCs) and agreed EU communication plans to drive safety notices, RMP updates, and HCP communications.

• EMA European Shortages Monitoring Platform (ESMP) and shortages catalogues to anticipate EU supply constraints and coordinate mitigation.

• EMA newsletters/CTIS newsflashes and press materials to track procedural or system changes impacting trial submissions and post‑authorisation monitoring.

Alert cadence examples

Parakeet delivers both real‑time notices and scheduled digests, tuned per source and business risk.

Daily (real‑time or batched)

• New FDA guidance posted (e.g., CDER item) → trigger “policy/control review” task with owner and due date.

• FDA safety recall for a relevant product class → open change‑control and notify labeling/quality leads.

• FDA Drug Shortage entry status change (current→resolved or new listing) → notify supply planning and procurement.

• EMA DHPC published for product/therapeutic area → notify safety/pharmacovigilance to update communications and RMP.

Weekly digest

• “Guidance & Safety Weekly” summarizing FDA/EMA guidance issuances, shortage trends, and any DHPCs impacting the portfolio, with links to original notices and internal tasks.

• “EU Regulatory Ops” summarizing new/updated EMA guidelines and CTIS newsflashes affecting trial submissions.

Message examples (Slack and Teams)

Parakeet posts directly to your collaboration tools; see integrations for Slack and Microsoft Teams.

Example Slack post

• Channel: #reg‑intel

• Title: FDA Guidance Issued — topic: Data Integrity in Analytical Methods

• Summary: New CDER guidance issued; effective upon publication. Impacted SOPs: QMS‑DOC‑014, LAB‑VAL‑022. Action: Complete gap analysis by Nov 12, 2025.

• Buttons: View Source • Create Tasks • Assign Owners

Example Teams post

• Team: Regulatory Affairs

• Card: EMA DHPC — Product: Aflibercept (Eylea); Signal: Higher risk of intraocular pressure increase with pre‑filled syringe.

• Linked Workflows: Labeling review; HCP comms approval; CAPA tracking.

• Buttons: Open in Parakeet • View DHPC • Start Change Control.

Routing matrix (who gets what, where, and when)

Evidence handling and audit readiness

Parakeet stores the original notice, normalized metadata (issue date, status, product/class, geography), and the full decision trail (who triaged, what changed, when). Electronic records and signatures are managed in line with FDA’s 21 CFR Part 11 scope and enforcement guidance, including validation, audit trails, record retention, and copies in human‑readable formats.

Configuration highlights

• Sources and filters: limit by therapeutic areas, product keywords, regions, and dossier lifecycle stage; de‑duplicate cross‑posted items across sources.

• Workflows: map alerts to SOPs, CAPAs, and change controls in your existing QMS; assign SLAs and escalation paths.

• Delivery: choose Slack, Teams, WhatsApp, and Google Calendar reminders; configure quiet hours and digest windows. See Slack, Teams, WhatsApp, and Google Calendar integrations.

• Research assistance: use the Rosella AI Agent to summarize guidance diffs, draft policy redlines, and generate audit evidence packets; platform capabilities on Features.

Source list (authoritative)

• FDA — Search for Guidance Documents (sortable by issue date; supports email updates).

• FDA — Recalls, Market Withdrawals & Safety Alerts.

• FDA — Drug Shortages (current/resolved; DSS program).

• EMA — Scientific Guidelines (human medicines).

• EMA — DHPCs (EU‑level HCP safety communications).

• EMA — European Shortages Monitoring Platform (ESMP) and shortages catalogues.

• EMA — Newsletters/CTIS newsflash.

Covered authorities & feeds (what we parse and store)

Below is the authoritative coverage used to power eQMS workflows and TPRM oversight. Each item is normalized with structured fields for routing, audit, and reporting.

Field dictionary (normalized record)

• issue_date: Date the notice/guidance is published.

• effective_date: Date requirements take effect (if specified).

• compliance_deadline: Derived or stated date by which actions must be complete.

• status: Current state (e.g., new/updated/rescinded; current/resolved for shortages).

• source_authority: FDA or EMA.

• feed_type: Guidance, Recall, Shortage, DHPC, Guideline, CTIS, etc.

• product_name/product_class/therapeutic_area: Normalized product or class metadata.

• geography/jurisdiction: U.S., EU, or member‑state specifics.

• citation_id/identifier: Native identifier if provided.

• link_to_notice: URL of the original authoritative notice.

• tags: Free‑text keywords and mapped SOP/control IDs.

Sample normalized record (shape)

{
 "source_authority": "FDA",
 "feed_type": "Guidance",
 "topic": "Data Integrity in Analytical Methods",
 "issue_date": "2025-10-02",
 "effective_date": "2025-10-02",
 "compliance_deadline": "2025-11-12",
 "product_class": ["Small Molecule", "QC Labs"],
 "therapeutic_area": ["Multiple"],
 "status": "new",
 "citation_id": "CDER-2025-XXXX",
 "link_to_notice": "<authoritative URL>",
 "tags": ["QMS-DOC-014", "LAB-VAL-022"]
}

FAQs

• What authorities and feeds are covered? FDA: Guidance, Recalls/Market Withdrawals/Safety Alerts, Drug Shortages (DSS). EMA: Scientific Guidelines, DHPC, ESMP/Shortages, CTIS/newsletters.

• Which fields are extracted for audit and routing? Core fields include issue_date, effective_date, compliance_deadline, status, product/class, jurisdiction, identifier, link_to_notice, and mapped SOP/control tags.

• How do you route alerts into our QMS and supplier workflows? We map feed_type and risk rules to your SOPs/CAPAs/change controls and auto‑create tasks in your eQMS and TPRM vendor records with owners and SLAs.

• How is 21 CFR Part 11 addressed? Electronic records/signatures, audit trails, retention, and human‑readable copies are maintained per 21 CFR Part 11 scope and enforcement guidance.

ICH Q9 and ISO 14971 Quality Risk Management (QRM) — eQMS integration

Parakeet maps regulatory signals to QRM artifacts so Quality teams can operationalize ICH Q9 and ISO 14971 inside existing eQMS and supplier workflows.

Signal-to-QRM mappings (examples)

• FDA/EMA guidance issuance → Update risk assessment rationale; refresh risk matrix; trigger FMEA/Control Plan review; open change control aligned to impacted SOPs.

• Recall/Safety alert (FDA/EMA DHPC) → Hazard analysis update; benefit–risk evaluation; labeling risk control check; CAPA with verification/validation tasks; RMP update.

• Drug shortage (FDA DSS/EMA ESMP) → Supply continuity risk assessment; mitigation actions in risk register; supplier requalification or alternate sourcing FMEA.

• CTIS/newsflashes (EMA) → Clinical risk assessment update; protocol/control changes routed via change control; traceability to decision log.

• Scientific guidelines (EMA) → Dossier/QMS control mapping; design control risk files refreshed; residual risk acceptability re-justified.

QRM artifacts auto-generated/mapped

• Risk register entries with severity/occurrence/detectability and calculated risk priority values.

• Risk matrices linked to products, processes, and suppliers with before/after control scoring.

• FMEA/FMECA sections prefilled from normalized signal metadata; verification/validation tasks attached.

• Hazard analysis and risk control traceability to SOPs, CAPAs, and change controls.

• Decision logs and benefit–risk justifications with Part 11 e‑signatures and full audit trails.

FAQ — ICH Q9/ISO 14971

• Do you support ICH Q9 and ISO 14971 workflows? Yes. Signals are routed into risk assessments, matrices, FMEA/FMECA, and hazard analyses with traceability to controls, CAPAs, and change control in your eQMS.

• How are risk matrices and FMEA kept current? When a monitored notice matches your portfolio, Parakeet opens/update tasks, prepopulates fields (severity, occurrence, detectability), and captures approvals with audit trails.

• Can Rosella help author QRM artifacts? Rosella summarizes changes, drafts risk rationales, proposes control updates, and assembles evidence packets; teams review/approve within validated workflows.

• How does this align with 21 CFR Part 11? Risk records, signatures, and audit trails are Part 11‑ready with validation support, human‑readable copies, and exportable evidence mapped to your SOPs.

Get started

• Talk with our team to tailor the routing matrix and cadences for your portfolio on Pharma.

• Explore continuous monitoring and incident orchestration on Continuous Compliance.